SpliSense has raised $28.5 million in funding to advance its antisense oligonucleotide (ASO) platform for the treatment of cystic…
Articles by Marta Figueiredo, PhD
Pel, a complex sugar molecule produced by Pseudomonas aeruginosa, contributes to the bacterium’s ability to aggregate and resist both…
The United States Adult CF Association (USACFA) is accepting applications to award a total of $15,000 in scholarships to…
Work targeting new therapies against antibiotic-resistant infections, led by West Virginia University (WVU) researchers, received a $1.4 million grant…
Researchers have developed a patient-derived model of cystic fibrosis (CF) to better understand whether these patients are more susceptible…
People with rare disorders have a worse healthcare experience than those affected by chronic diseases, according to the results of…
ELX-02 restored the levels and function of CFTR — the defective protein in CF — in “mini-organs,” or organoids,…
Cystic fibrosis (CF) patients and carriers — those with mutations in only one copy of the CFTR, the gene…
Limits placed on social interaction by the COVID‐19 pandemic appear to have led to a drop in the number of pulmonary…
The U.S. Food and Drug Administration (FDA) has expanded the number of cystic fibrosis (CF)-related mutations considered responsive to and…